Incyte Corp’s recent filing unveils that its EVP & Chief Medical Officer Stein Steven H unloaded Company’s shares for reported $0.9 million on Jan 21 ’25. In the deal valued at $72.69 per share,12,352 shares were sold. As a result of this transaction, Stein Steven H now holds 66,967 shares worth roughly $4.44 million.
Then, STEVEN STEIN bought 12,352 shares, generating $897,906 in total proceeds.
Before that, Tray Thomas sold 650 shares. Incyte Corp shares valued at $45,916 were divested by the Principal Accounting Officer at a price of $70.64 per share. As a result of the transaction, Tray Thomas now holds 23,962 shares, worth roughly $1.59 million.
UBS initiated its Incyte Corp [INCY] rating to a Neutral in a research note published on December 17, 2024; the price target was $77. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in late October from “a Neutral” to “a Buy”. Wolfe Research began covering INCY with “an Outperform” recommendation on October 01, 2024. Truist revised its rating on September 18, 2024. It rated INCY as “a Hold” which previously was an “a Buy”.
Price Performance Review of INCY
On Tuesday, Incyte Corp [NASDAQ:INCY] saw its stock fall -2.88% to $66.33. Over the last five days, the stock has lost -10.51%. Incyte Corp shares have fallen nearly -3.97% since the year began. Nevertheless, the stocks have risen 15.64% over the past one year. While a 52-week high of $83.95 was reached on 02/07/25, a 52-week low of $50.35 was recorded on 02/11/25. SMA at 50 days reached $71.81, while 200 days put it at $65.96.
Levels Of Support And Resistance For INCY Stock
The 24-hour chart illustrates a support level at 65.50, which if violated will result in even more drops to 64.66. On the upside, there is a resistance level at 67.93. A further resistance level may holdings at 69.52. The Relative Strength Index (RSI) on the 14-day chart is 29.79, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.23, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.35%. Stochastics %K at 20.21% indicates the stock is a holding.
How much short interest is there in Incyte Corp?
A steep rise in short interest was recorded in Incyte Corp stocks on 2025-01-15, dropping by -0.83 million shares to a total of 5.04 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 5.87 million shares. There was a decline of -16.41%, which implies that there is a negative sentiment for the stock.
